Given the exclusiveness of R132C to all Li-Fraumeni glioma, and the hallmark of the syndrome being an established TP53 germline mutation, it is posited that subtype R132C mutation is favored by glioma progenitors when it occurs after a TP53 mutation. This evidence concerns the gene TP53 and central nervous system cancer.